Nanobiology for the pharmacology of cellular ion channels.
Writing this editorial is especially pleasing. First, it provides us an opportunity to introduce new directives to the field of Neuroimmune Pharmacology and to explain why the field of nanomedicine is likely an important part of its future growth and development. Second, it is an opportunity to showcase research in this area currently operative in Russia that may not be readily accessible to the readership. Third, it is a platform to better explain why the Journal Editorial leadership was enthusiastic about the science and its relationship to the Society on NeuroImmune Pharmacology strategic goals. All are brought to bear in this issue of the Journal of Neuroimmune Pharmacology. The issue includes articles presented at a recent joint US-Russian workshop entitled, "Health in the 21st Century: Nanomedicine and Self-Organization of Biological Systems" held at M.V. Lomonosov Moscow State University (MSU), Moscow, Russia, December 10-11, 2007. The conjoint meeting was organized through the Departments of Biology, Chemistry, and Physics, MSU and by the Center for Drug Delivery and Nanomedicine and Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center (Omaha, NE). The speakers included established internationally regarded scientists from these institutions as well as graduate students and faculties at MSU. In addition to selected papers by workshop contributors, we have included several papers closely aligned to the theme of nanomedicine and nanopharmacology of the central nervous system in order to provide a biological anchor for this research. We understand that such works are new to many but hope that its organization and interdisciplinary approaches will appeal to this audience. All together, it is our hope that, by gathering basic and clinical scientists with the common interest of using nanotechnology in the delivery of therapeutic agents with a focus on nanopharmacology and complex supramolecular biological assembly, the papers included will provide a platform for thought, discussion, and future translational research.
Kabanov
Alexander V
AV
Center for Drug Delivery and Nanomedicine, Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, 985830 Nebraska Medical Center, Omaha, NE 68198-5830, USA. akabanov@unmc.edu
Kirpichnikov
Mikhail P
MP
Khokhlov
Alexey R
AR
D015658:HIV Infections / Q000378:metabolism; D006801:Humans; D007473:Ion Channels / Q000187:drug effects*; D036103:Nanotechnology / Q000639:trends*; D009419:Nerve Tissue Proteins / Q000096:biosynthesis; D015213:Neuroimmunomodulation / Q000502:physiology*; D009488:Neurosciences / Q000639:trends; D017232:Oncogene Proteins v-mos / Q000378:metabolism; D015221:Potassium Channels / Q000187:drug effects
D007473:Ion Channels; D009419:Nerve Tissue Proteins; D017232:Oncogene Proteins v-mos; D015221:Potassium Channels